Clinical Trials Browser

Phase 2/3 × Colonic Neoplasms × 30 days × Clear all

NCT05174169 2026-04-02

CIRCULATE-US

Phase 2/3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT02758951 2026-03-24

CAIRO6

Phase 2/3 Active not recruiting

GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT05179889 2026-03-19

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Phase 2/3 Recruiting

Gastrointestinal

Colonic Neoplasms